(Press-News.org) Huntsman Cancer Institute shines the spotlight on new discoveries and cutting-edge cancer research. This month, researchers found that increasing access for Black people with prostate cancer may save lives. Also, the first patient in a new small cell lung cancer clinical trial has been enrolled, researchers are using an app to help adolescents and young adults manage cancer symptoms, and investigators are trying to reduce cognitive side-effects after chemotherapy.
Increasing access to Black people with prostate cancer may decrease mortality rate
In a study published in JAMA Network Open, researchers at Huntsman Cancer Institute found that making care more accessible to Black people with prostate cancer could decrease the mortality rate. Investigators had believed that since Black patients suffer from more aggressive forms of prostate cancer, their mortality rates were lower than White patients. Neeraj Agarwal, MD, FASCO, physician-scientist at Huntsman Cancer Institute, and his team showed that Black patients had similar survival outcomes to white patients when they had equal access to cancer care and treatment.
First patient in a small cell lung cancer targeted therapy clinical trial treated
Huntsman Cancer Institute became the first U.S. facility to offer a phase 1 clinical trial for extensive stage small cell lung cancer with a targeted radiopharmaceutical therapy. Because small cell lung cancer is very aggressive, new targeted therapies are needed. When patients are considered for the clinical trial, they undergo a special scan. The scan helps assess whether they have the specific gene targeted by the drug. If the patient’s scan is positive, researchers can move forward with the targeted therapy. Sonam Puri, MD, physician-scientist at Huntsman Cancer Institute, leads the clinical trial.
Engaging adolescents and young adults with cancer through an app
The National Cancer Institute provided an R01 grant to Huntsman Cancer Institute investigators to conduct a multisite clinical trial to help adolescents and young adults (AYAs) manage their cancer symptoms. Lauri Linder, PhD, APRN, member of the Cancer Control and Population Sciences program at Huntsman Cancer Institute, created an app to engage AYAs to report their symptom experiences. AYAs use Dr. Linder’s app to create a diagram that shows the symptoms they are experiencing, how their symptoms are related, and which are most important to them. AYAs will use their symptom diagram during doctor visits to discuss and develop a plan to manage their symptoms. Dr. Linder’s team hopes to improve AYAs’ ability to manage their cancer-related symptoms.
Reducing chemo side-effects after treatment
While receiving chemotherapy, it is common to experience cognitive issues, also known as chemo brain. These symptoms can occur during treatment, but often also persist for months or years post remission. In a study published in Digital Health, researchers found that cognitive games, developed at the University of Utah can improve memory, attention, and mood in women who experienced persistent chemo brain. Huntsman Cancer Institute researcher Sarah Shizuko Morimoto, PSYD, and her team, also noted that patients were able to accurately perceive their abilities and as their cognition improved, so did perception of their cognitive function.
About Huntsman Cancer Institute at the University of Utah
Huntsman Cancer Institute at the University of Utah (the U) is the official cancer center of Utah and the only National Cancer Institute-designated Comprehensive Cancer Center in the Mountain West. The institute is leading the world in scientific discovery, and turning it into unsurpassed cancer care, transforming hope into a reality. Huntsman Cancer Institute focuses on delivering a cancer-free frontier to Utah, Idaho, Montana, Nevada, and Wyoming (The Area We Serve). Huntsman Cancer Institute is home to over 300 clinical trials, with over 237 research teams studying cancer at any given time and more genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Huntsman Cancer Institute’s scientists are world renown for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patient’s unique tumor. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.
Research Highlights for September 2023
ELSE PRESS RELEASES FROM THIS DATE:
JMIR Publications places No, 348 on The Globe and Mail's annual ranking of Canada's Top Growing Companies
(Toronto, September 29, 2023) JMIR Publications is pleased to announce it placed No. 348 on the 2023 Report on Business ranking of Canada’s Top Growing Companies, making the ranking over the past three consecutive years. Canada’s Top Growing Companies ranks Canadian companies on three-year revenue growth. JMIR Publications earned its spot with three-year growth of 105%. “Being ranked on this list, year over year, showcases JMIR Publications’ national and global leadership in publishing high-quality open access ...
Argonne National Laboratory launches South Side STEM Opportunity Landscape Project at DuSable Black History Museum and Education Center
A transformative initiative aimed at identifying, enhancing and promoting science, technology, engineering and mathematics resources within local communities. The U.S. Department of Energy’s Argonne National Laboratory is proud to announce the official launch of the South Side STEM Opportunity Landscape Project, a transformative initiative aimed at identifying, enhancing and promoting science, technology, engineering and mathematics (STEM) resources within local communities. As part of the Argonne in Chicago initiative that includes offices in Hyde Park, the ...
Allergy study on 'wild' mice challenges the hygiene hypothesis
The notion that some level of microbial exposure might reduce our risk of developing allergies has arisen over the last few decades and has been termed the hygiene hypothesis. Now, an article published in Science Immunology by researchers from Karolinska Institutet challenges this hypothesis by showing that mice with high infectious exposures from birth have the same, if not an even greater ability to develop allergic immune responses than 'clean' laboratory mice. How microbes may prevent allergy has been a topic of great interest in recent times. Studies have suggested that certain infections might reduce the production of inflammatory antibodies to ...
Ancient plant wax reveals how global warming affects methane in Arctic lakes
New study makes novel use of plant biomarkers preserved in sediment to reconstruct methane cycling over the past 10,000 years Plant waxes hold an isotopic signature of ancient methane As planet warmed due to slow changes in Earth’s orbit, lakes produced increased amounts of methane, which is a potent greenhouse gas Researcher: ‘Living on a warming planet, we can look to these signs from the past to predict our future’ EVANSTON, Ill. — By studying fossils from ancient aquatic plants, ...
Atopic dermatitis: Viruses discovered as new therapy option
Up to 15 percent of children and five percent of adults are affected by the chronic inflammatory skin disease atopic dermatitis. Despite advanced therapy measures, the severe itching and eczema, especially on the elbows or knees, cause great distress to the patients. In the course of a study conducted at MedUni Wien a research team led by Wolfgang Weninger, Head of the Department of Dermatology, has discovered a new approach: bacteriophages, which colonize the skin as viral components of the microbiome and can drive the development of innovative ...
Larger lymph node threshold optimizes nasopharyngeal carcinoma outcomes
Leesburg, VA, September 29, 2023—According to the American Journal of Roentgenology (AJR), using a 6-mm threshold, rather than a 5-mm threshold, helps facilitate better risk stratification and treatment decisions in patients with nasopharyngeal carcinoma (NPC). “Future American Joint Committee on Cancer (AJCC) staging updates should consider incorporation of the 6-mm threshold for N-category and tumor-stage determinations,” wrote corresponding author Zhiying Liang, MD, from the radiology department at China’s Sun Yat-sen University Cancer Center. This AJR accepted manuscript by Liang et al. included ...
BPS celebrates Max Planck-Humboldt medal awardee Kandice Tanner
ROCKVILLE, MD – The Biophysical Society is honored to celebrate Kandice Tanner, a physicist and Senior Investigator at the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH) in Bethesda, Maryland. Tanner is being recognized for her pioneering work on the biophysics of the metastatic spread of cancer. Using 3D organoid models of cancer progression, Tanner discovered a novel type of cell migration and cell generated forces associated with the formation of microtissues and tumors. This discovery demonstrated that physical forces are important in the establishment ...
Cleveland Clinic researchers develop new model for prioritizing lung transplant candidates
September 29, 2023, CLEVELAND: A team from Cleveland Clinic has developed a new model for prioritizing patients waiting for a lung transplant, aimed at improving outcomes and reducing deaths among those in need of donor lungs. The new method offers an improved strategy for organ allocation by taking into account how the time a patient has spent on the waiting list could impact the severity of their disease and the urgency of their need for a transplant. The results of a study looking at this new method were published today in The American Journal of Respiratory and Critical Care Medicine. Currently, ...
American Academy of Arts and Sciences to induct UVA's Garcia-Blanco
The University of Virginia School of Medicine’s Mariano A. Garcia-Blanco, MD, PhD, will be inducted this weekend into the American Academy of Arts and Sciences (AAAS), one of the country’s oldest and most prestigious honorary societies, in recognition of his exceptional scientific contributions. The AAAS was founded in 1780 – during the Revolutionary War – by John Adams, John Hancock and other founding fathers who wanted to “cultivate every art and science which may tend to advance the interest, honor, dignity and ...
Illinois-led team puts cows and microbes to work to reduce greenhouse gases
URBANA, Ill. — As we hurtle toward crucial tipping points on a warming planet, an international team of scientists is recruiting a surprising ally to make a powerful dent in greenhouse gas emissions: the cow. Animal sciences researchers from the University of Illinois Urbana-Champaign are driving a new project to reduce methane production resulting from rumen fermentation in beef and dairy cattle. The 3-year, $3.2-million project is part of the Greener Cattle Initiative, led by the Foundation for Food and Agriculture Research (FFAR). According to the researchers, aggressively targeting methane could help course-correct our climate trajectory on a quicker timeline ...